Latest EXPAREL Stories
PARSIPPANY, N.J., March 31, 2011 /PRNewswire/ -- Pacira Pharmaceuticals, Inc.
SAN DIEGO and PARSIPPANY, N.J., March 2, 2011 /PRNewswire/ -- Pacira Pharmaceuticals, Inc., (Nasdaq: PCRX), an emerging specialty pharmaceutical company, today announced that positive results from its Phase 1 study evaluating EXPAREL(TM) (bupivacaine extended-release liposome injection) in patients with moderate hepatic impairment, will be presented at the 2011 American Society for Clinical Pharmacology and Therapeutics (ASCPT) 112th Annual Meeting in Dallas, TX.
SAN DIEGO, and PARSIPPANY, N.J., Feb.
PARSIPPANY, N.J., Jan.